| Secondary |
| Product Used For Unknown Indication |
26.5% |
| Cardiac Failure |
11.9% |
| Hypertension |
11.5% |
| Tachycardia |
6.7% |
| Hodgkin's Disease |
5.9% |
| Ejection Fraction Decreased |
4.7% |
| Coronary Artery Disease |
3.2% |
| Non-hodgkin's Lymphoma |
3.2% |
| Peripheral Vascular Disorder |
3.2% |
| Chronic Obstructive Pulmonary Disease |
2.8% |
| Diabetes Mellitus |
2.8% |
| Asthma |
2.4% |
| Hypercholesterolaemia |
2.4% |
| Pain |
2.4% |
| Suicide Attempt |
2.4% |
| Myocardial Ischaemia |
2.0% |
| Depression |
1.6% |
| Hyperlipidaemia |
1.6% |
| Myocardial Infarction |
1.6% |
| Thrombophlebitis Superficial |
1.6% |
|
| Eosinophilic Myocarditis |
11.1% |
| Cardiac Arrest |
9.3% |
| Deep Vein Thrombosis |
7.4% |
| Acidosis |
5.6% |
| Alopecia |
5.6% |
| Foetal Growth Restriction |
5.6% |
| Respiratory Distress |
5.6% |
| Torsade De Pointes |
5.6% |
| Acute Myocardial Infarction |
3.7% |
| Anaemia Macrocytic |
3.7% |
| Blood Pressure Decreased |
3.7% |
| Coronary Artery Thrombosis |
3.7% |
| Disease Progression |
3.7% |
| Eosinophilia |
3.7% |
| Heart Rate Increased |
3.7% |
| Heart Rate Irregular |
3.7% |
| Ischaemic Stroke |
3.7% |
| Pulmonary Fibrosis |
3.7% |
| Suicide Attempt |
3.7% |
| Toxic Skin Eruption |
3.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.9% |
| Drug Use For Unknown Indication |
10.6% |
| Hypertension |
10.5% |
| Rheumatoid Arthritis |
5.8% |
| Asthma |
3.0% |
| Cardiac Disorder |
2.8% |
| Chronic Obstructive Pulmonary Disease |
2.6% |
| Coronary Artery Disease |
2.5% |
| Osteoporosis |
2.1% |
| Arthritis |
1.7% |
| Diabetes Mellitus |
1.7% |
| Arrhythmia |
1.6% |
| Atrial Fibrillation |
1.6% |
| Blood Cholesterol Increased |
1.6% |
| Infarction |
1.6% |
| Myocardial Infarction |
1.6% |
| Angina Pectoris |
1.5% |
| Aortic Bypass |
1.5% |
| Peripheral Arterial Occlusive Disease |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
|
| Thrombocytopenia |
12.8% |
| Renal Failure Acute |
8.1% |
| Interstitial Lung Disease |
5.8% |
| Multiple Myeloma |
5.8% |
| Pancreatitis Acute |
5.8% |
| Pyrexia |
5.8% |
| Anaemia |
4.7% |
| Dyspnoea |
4.7% |
| Overdose |
4.7% |
| Renal Failure |
4.7% |
| Tachycardia |
4.7% |
| Urinary Retention |
4.7% |
| Bone Marrow Failure |
3.5% |
| Cerebrovascular Accident |
3.5% |
| Cough |
3.5% |
| Electrocardiogram Qt Prolonged |
3.5% |
| Hypoglycaemia |
3.5% |
| International Normalised Ratio Increased |
3.5% |
| Leukopenia |
3.5% |
| Mitral Valve Incompetence |
3.5% |
|
| Interacting |
| Cardiac Failure |
32.6% |
| Product Used For Unknown Indication |
30.2% |
| Asthma |
9.3% |
| Diabetes Mellitus |
4.7% |
| Hypertension |
4.7% |
| Insomnia |
4.7% |
| Acute Coronary Syndrome |
2.3% |
| Back Pain |
2.3% |
| Cardiac Failure Chronic |
2.3% |
| Hypercholesterolaemia |
2.3% |
| Ischaemic Heart Disease Prophylaxis |
2.3% |
| Thrombosis Prophylaxis |
2.3% |
|
| Overdose |
30.0% |
| Torsade De Pointes |
30.0% |
| Cardioactive Drug Level Increased |
10.0% |
| Lung Disorder |
10.0% |
| Miosis |
10.0% |
| Sinus Bradycardia |
10.0% |
|
